Rx (Prescription Medicine)
USD $ 30.00
Tiova Inhaler 200mdi 是一种定量吸入剂，含有溴化铵（Tiotropium Bromide），一种长效抗胆碱能药物。它通过阻断乙酰胆碱的作用来实现，乙酰胆碱是一种在肺部会导致气道收缩的物质。通过抑制乙酰胆碱，Tiova Inhaler 有助于放松并打开气道，使呼吸更加顺畅。
该药物主要用于慢性阻塞性肺疾病（COPD）患者的长期、每日一次的维持治疗，包括慢性支气管炎和肺气肿。它还用于降低 COPD 患者的急性发作次数。
Tiova Inhaler 200mdi 的常规用法为每日一次吸入一次。请务必按医嘱定期使用此药物，即使您感觉良好也不要停用。不要用于急性呼吸困难的紧急缓解。
常见的不良反应可能包括口干、喉咙痛、声音嘶哑以及便秘。较少见的不良反应包括视力模糊、排尿困难以及心率加快。若出现任何严重或持续的不良反应，请立即就医。
请将 Tiova Inhaler 200mdi 存放于室温，避免受热和直射阳光。放在儿童不易触及的地方。使用前请确保吸入器清洁，口嘴部无杂质。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Pack Quantity |
其他品牌的 Tiotropium 9 Mcg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
